Episode 12: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host Dr. Karen L. Reckamp, MD, MS, Department of Medicine, Division of Medical Oncology, Cedars Sinai Medical Center, author of the September Journal of Thoracic Oncology article, The Evolution of Immunotherapy Revolution in Lung Cancer: a 20-Year Perspective.
Recommended Reading:
The Evolution of Immunotherapy Revolution in Lung Cancer: a 20-Year Perspective
Volume 21, Issue 9: https://www.jto.org/issue/S1556-0864(26)X2009-3
Host Names & Titles:
Alex A. Adjei, MD, PhD, FACP
Editor-in-Chief, Journal of Thoracic Oncology
Chief, Taussig Cancer Institute,
Cleveland Clinic, Ohio, United States.
X: @DrAlexAdjei
LinkedIn: https://www.linkedin.com/in/alex-adjei-9434bb16b/
Thomas John, MBBS, PhD
Associate Editor, Journal of Thoracic Oncology
Deputy Director, Medical Oncology, Peter MacCallum Cancer Centre,
Melbourne, Australia.
X: @TommyJohn00;
Bluesky: @drtomjohn@bsky.social
LinkedIn: https://www.linkedin.com/in/tom-john-1084ab362/
Guest Name & Title:
Karen L. Reckamp, MD, MS, Department of Medicine, Division of Medical Oncology, Cedars Sinai Medical Center, Los Angeles, California
LinkedIn: https://www.linkedin.com/in/karen-reckamp-md-7525419/